Maxalt
This medication is developed to target acute migraine attacks and support relief of associated symptoms through specific receptor action.
Strengths: 5 · 10mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Maxalt Melt
- Therapeutic class
5-HT1 Receptor Agonist
- Pharmacological class
Triptan
- Precautions and warnings
do not use for prevention; use with caution in elderly patients
- Minor side effects
dizziness; somnolence; paresthesia
- Moderate side effects
nausea; dry mouth
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Merck Sharp & Dohme
- Onset Time
30–60 minutes
- Duration
4–6 hours
- Storage instructions
Store at room temperature in a dry place.
- Drug interactions
MAO inhibitors; Ergotamine; SSRIs
- Age restrictions
Not recommended for under 18 years.
Contraindications
hypersensitivity to rizatriptan; history of ischaemic heart disease; uncontrolled hypertension
Serious side effects
myocardial infarction — requires immediate medical attention; cerebrovascular accident — requires immediate medical attention
Patient summary
This medication is developed to target acute migraine attacks and support relief of associated symptoms through specific receptor action.
Mechanism of action
Rizatriptan is a selective serotonin 5-HT1B/1D receptor agonist that constricts intracranial blood vessels and inhibits the release of neuropeptides involved in migraine pain.
Pregnancy and breastfeeding
Pregnancy: Use only if necessary. Breastfeeding: Exercise caution; consult a specialist.
Maxalt
This medication is developed to target acute migraine attacks and support relief of associated symptoms through specific receptor action.
Editorial Notes
- Active ingredient(s): Rizatriptan
- Listed indication(s): Migraine
Usually available as
- 28 tablets - 5 mg456-5-mg-3437
- 20 tablets - 10 mg456-10-mg-3442